PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors

Scott Kopetz1, Jayesh Desai2, Emily Chan3, J Randolph Hecht4 , Peter J O’Dwyer5, Richard J Lee6, Keith B Nolop7, Suman Bhattacharya8, Leonard Saltz9

1 The University of Texas M.D. Anderson Cancer Center, Houston, TX; 2 Royal Melbourne Hospital, Parkville, Australia;

3 Vanderbilt-Ingram Cancer Center, Nashville, TN; 4 David Geffen School of Medicine at UCLA, Los Angeles, CA;

5 Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA; 6 Roche, Nutley, NJ;

7 Plexxikon, Berkeley, CA; 8 Genentech, Inc., South San Francisco, CA;

9 Memorial Sloan-Kettering Cancer Center, New York, NY

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534

Kopetz, Desai, et al ASCO 2010 Abs# 3534